Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Day 14	STARTED	1 Artemether-Lumefantrine	204
Day 14	STARTED	2 Amodiaquine- Artesunate	612
Day 14	COMPLETED	1 Artemether-Lumefantrine	192
Day 14	COMPLETED	2 Amodiaquine- Artesunate	563
Day 14	NOT COMPLETED	1 Artemether-Lumefantrine	12
Day 14	NOT COMPLETED	2 Amodiaquine- Artesunate	49
Day 28	STARTED	1 Artemether-Lumefantrine	192
Day 28	STARTED	2 Amodiaquine- Artesunate	563
Day 28	COMPLETED	1 Artemether-Lumefantrine	176
Day 28	COMPLETED	2 Amodiaquine- Artesunate	540
Day 28	NOT COMPLETED	1 Artemether-Lumefantrine	16
Day 28	NOT COMPLETED	2 Amodiaquine- Artesunate	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00297882/flow